Keratoconus Treatment Market Research Report Information by Keratoconus Type (Corneal Hydrops, Forme Fruste Keratoconus, Posterior Keratoconus, Keratoglobus, Pellucid Marginal Degeneration), Treatment Type (Lenses, Surgery, Corneal Cross-Linking), End User (Eye Clinics, Hospitals), and Region(Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2032

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 14

1.1 OVERVIEW 14

2 MARKET INTRODUCTION 15

2.1 SCOPE OF THE STUDY 15

2.2 RESEARCH OBJECTIVE 15

2.3 LIST OF ASSUMPTIONS 16

3 RESEARCH METHODOLOGY 17

3.1 OVERVIEW 17

3.2 DATA MINING 17

3.3 SECONDARY RESEARCH 18

3.4 PRIMARY RESEARCH 19

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 19

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 20

3.5 FORECASTING TECHNIQUES 21

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22

3.6.1 BOTTOM-UP APPROACH 22

3.6.2 TOP-DOWN APPROACH 23

3.7 DATA TRIANGULATION 24

3.8 VALIDATION 24

4 MARKET DYNAMICS 25

4.1 INTRODUCTION 25

4.2 DRIVERS 26

4.2.1 INCREASING INCIDENCE AND PREVALENCE OF THE KERATOCONUS DISORDER 26

4.2.2 INCREASING ULTRAVIOLET AND SUN EXPOSURE 26

4.2.3 FAVORABLE GOVERNMENT FUNDING 27

4.3 RESTRAINTS 28

4.3.1 LACK OF AWARENESS 28

4.3.2 SIDE-EFFECTS OF KERATOCONUS TREATMENT 28

4.4 OPPORTUNITIES 29

4.4.1 EMERGING MARKETS OF KERATOCONUS TREATMENT 29

5 MARKET FACTOR ANALYSIS 30

5.1 VALUE CHAIN ANALYSIS 30

5.1.1 R&D AND DESIGNING 31

5.1.2 MANUFACTURING 31

5.1.3 DISTRIBUTION 31

5.1.4 MARKETING & SALES 31

5.2 PORTER’S FIVE FORCES MODEL 31

5.2.1 THREAT OF NEW ENTRANTS 32

5.2.2 BARGAINING POWER OF SUPPLIERS 32

5.2.3 THREAT OF SUBSTITUTES 33

5.2.4 BARGAINING POWER OF BUYERS 33

5.2.5 INTENSITY OF RIVALRY 33

5.3 COVID-19 IMPACT ANALYSIS 33

5.3.1 IMPACT ON MARKET GROWTH 33

5.3.2 IMPACT ON DEMAND AND SUPPLY 34

5.3.3 IMPACT ON MAJOR PLAYERS 34

6 GLOBAL KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TYPE 35

6.1 OVERVIEW 35

6.2 CORNEAL HYDROPS 36

6.3 FORME FRUSTE KERATOCONUS 36

6.4 POSTERIOR KERATOCONUS 37

6.5 KERATOGLOBUS 37

6.6 PELLUCID MARGINAL DEGENERATION 38

6.7 OTHERS 38

7 GLOBAL KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE 39

7.1 OVERVIEW 39

7.2 CORNEAL CROSS-LINKING 40

7.3 LENSES 40

7.4 SURGERY 42

7.5 OTHERS 43

8 GLOBAL KERATOCONUS TREATMENT MARKET, BY END USER 44

8.1 OVERVIEW 44

8.2 EYE CLINICS 45

8.3 HOSPITALS 45

8.4 OTHERS 46

9 GLOBAL KERATOCONUS TREATMENT MARKET, BY REGION 47

9.1 OVERVIEW 47

9.2 AMERICA 48

9.2.1 NORTH AMERICA 52

9.2.1.1 US 55

9.2.1.2 CANADA 57

9.2.2 LATIN AMERICA 59

9.3 EUROPE 61

9.3.1 WESTERN EUROPE 64

9.3.1.1 GERMANY 67

9.3.1.2 FRANCE 69

9.3.1.3 UK 71

9.3.1.4 ITALY 73

9.3.1.5 SPAIN 75

9.3.1.6 REST OF WESTERN EUROPE 77

9.3.2 EASTERN EUROPE 79

9.4 ASIA-PACIFIC 81

9.4.1 CHINA 84

9.4.2 INDIA 86

9.4.3 JAPAN 88

9.4.4 SOUTH KOREA 90

9.4.5 AUSTRALIA 92

9.4.6 REST OF ASIA-PACIFIC 94

9.5 MIDDLE EAST & AFRICA 96

9.5.1 MIDDLE EAST 99

9.5.2 AFRICA 101

10 COMPETITIVE LANDSCAPE 103

10.1 OVERVIEW 103

10.2 COMPETITIVE BENCHMARKING 104

10.3 GLOBAL KERATOCONUS TREATMENT MARKET: COMPANY RANKING, 2020 105

10.4 MAJOR GROWTH STRATEGY IN THE GLOBAL KERATOCONUS TREATMENT MARKET 106

10.5 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 106

10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 107

10.6.1 PRODUCT APPROVALS AND LAUNCHES 107

10.6.2 ACQUISITIONS & SPIN OFF 108

10.7 FINANCIAL MATRIX 109

11 COMPANY PROFILES 110

11.1 BAUSCH HEALTH COMPANIES INC. 110

11.1.1 COMPANY OVERVIEW 110

11.1.2 FINANCIAL OVERVIEW 111

11.1.3 PRODUCTS/SERVICES OFFERED 112

11.1.4 KEY DEVELOPMENTS 112

11.1.5 SWOT ANALYSIS 113

11.1.6 KEY STRATEGIES 113

11.2 NOVARTIS AG 114

11.2.1 COMPANY OVERVIEW 114

11.2.2 FINANCIAL OVERVIEW 115

11.2.3 PRODUCTS/SERVICES OFFERED 115

11.2.4 KEY DEVELOPMENTS 116

11.2.5 SWOT ANALYSIS 116

11.2.6 KEY STRATEGIES 116

11.3 THE COOPER COMPANIES, INC. 117

11.3.1 COMPANY OVERVIEW 117

11.3.2 FINANCIAL OVERVIEW 117

11.3.3 PRODUCTS/SERVICES OFFERED 118

11.3.4 KEY DEVELOPMENTS 118

11.3.5 SWOT ANALYSIS 119

11.3.6 KEY STRATEGIES 119

11.4 HOYA CORPORATION 120

11.4.1 COMPANY OVERVIEW 120

11.4.2 FINANCIAL OVERVIEW 120

11.4.3 PRODUCTS/SERVICES OFFERED 121

11.4.4 KEY DEVELOPMENTS 121

11.4.5 SWOT ANALYSIS 122

11.4.6 KEY STRATEGIES 122

11.5 JOHNSON & JOHNSON SERVICES, INC. 123

11.5.1 COMPANY OVERVIEW 123

11.5.2 FINANCIAL OVERVIEW 124

11.5.3 PRODUCTS/SERVICES OFFERED 125

11.5.4 KEY DEVELOPMENTS 126

11.5.5 SWOT ANALYSIS 126

11.5.6 KEY STRATEGIES 126

11.6 CARL ZEISS MEDITEC AG 127

11.6.1 COMPANY OVERVIEW 127

11.6.2 FINANCIAL OVERVIEW 127

11.6.3 RODUCTS/SERVICES OFFERED 128

11.6.4 KEY DEVELOPMENTS 128

11.6.5 SWOT ANALYSIS 129

11.6.6 KEY STRATEGIES 129

11.7 CONTAMAC 130

11.7.1 COMPANY OVERVIEW 130

11.7.2 FINANCIAL OVERVIEW 130

11.7.3 PRODUCTS/SERVICES OFFERED 130

11.7.4 KEY DEVELOPMENTS 131

11.7.5 SWOT ANALYSIS 131

11.7.6 KEY STRATEGIES 131

11.8 SEED CO., LTD 132

11.8.1 COMPANY OVERVIEW 132

11.8.2 FINANCIAL OVERVIEW 132

11.8.3 PRODUCTS/SERVICES OFFERED 133

11.8.4 KEY DEVELOPMENTS 133

11.8.5 SWOT ANALYSIS 134

11.8.6 KEY STRATEGIES 134

11.9 SYNERGEYES 135

11.9.1 COMPANY OVERVIEW 135

11.9.2 FINANCIAL OVERVIEW 135

11.9.3 PRODUCTS/SERVICES OFFERED 135

11.9.4 KEY DEVELOPMENTS 136

11.9.5 SWOT ANALYSIS 136

11.9.6 KEY STRATEGIES 136

11.10 MENICON CO., LTD 137

11.10.1 COMPANY OVERVIEW 137

11.10.2 FINANCIAL OVERVIEW 137

11.10.3 PRODUCTS/SERVICES OFFERED 138

11.10.4 KEY DEVELOPMENTS 139

11.10.5 SWOT ANALYSIS 139

11.10.6 KEY STRATEGIES 139

12 APPENDIX 140

12.1 REFERENCES 140

12.2 RELATED REPORTS 140

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS& LIMITATIONS 16

TABLE 2 EPIDEMIOLOGY OF KERATOCONUS IN VARIOUS COUNTRIES AROUND THE WORLD, 2020 26

TABLE 3 GLOBAL: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TYPE, 2023-2032 (USD MILLION) 35

TABLE 4 GLOBAL: KERATOCONUS TREATMENT MARKET, FOR CORNEAL HYDROPS, BY REGION, 2023-2032 (USD MILLION) 36

TABLE 5 GLOBAL: KERATOCONUS TREATMENT MARKET, FOR FORME FRUSTE KERATOCONUS, BY REGION, 2023-2032 (USD MILLION) 36

TABLE 6 GLOBAL: KERATOCONUS TREATMENT MARKET, FOR POSTERIOR KERATOCONUS, BY REGION, 2023-2032 (USD MILLION) 37

TABLE 7 GLOBAL: KERATOCONUS TREATMENT MARKET, FOR KERATOGLOBUS, BY REGION, 2023-2032 (USD MILLION) 37

TABLE 8 GLOBAL: KERATOCONUS TREATMENT MARKET, FOR PELLUCID MARGINAL DEGENERATION, BY REGION, 2023-2032

(USD MILLION) 38

TABLE 9 GLOBAL: KERATOCONUS TREATMENT MARKET, BY TREAMENT TYPE, 2023-2032 (USD MILLION) 39

TABLE 10 GLOBAL: KERATOCONUS TREATMENT MARKET, FOR CORNEAL CROSS-LINKING, BY REGION, 2023-2032 (USD MILLION) 40

TABLE 11 GLOBAL: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY REGION, 2023-2032 (USD MILLION) 41

TABLE 12 GLOBAL: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE, 2023-2032 (USD MILLION) 41

TABLE 13 GLOBAL: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY REGION, 2023-2032 (USD MILLION) 42

TABLE 14 GLOBAL: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 43

TABLE 15 GLOBAL: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 44

TABLE 16 GLOBAL: KERATOCONUS TREATMENT MARKET, FOR EYE CLINICS, BY REGION, 2023-2032 (USD MILLION) 45

TABLE 17 GLOBAL: KERATOCONUS TREATMENT MARKET, FOR HSOPITALS, BY REGION, 2023-2032 (USD MILLION) 46

TABLE 18 GLOBAL: KERATOCONUS TREATMENT MARKET, BY REGION, 2023-2032 (USD MILLION) 48

TABLE 19 AMERICA: KERATOCONUS TREATMENT MARKET, BY REGION, 2023-2032 (USD MILLION) 49

TABLE 20 AMERICA: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TYPE, 2023-2032 (USD MILLION) 50

TABLE 21 AMERICA: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 50

TABLE 22 AMERICA: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE,2023-2032 (USD MILLION) 51

TABLE 23 AMERICA: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE,2023-2032 (USD MILLION) 51

TABLE 24 AMERICA: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 51

TABLE 25 NORTH AMERICA: KERATOCONUS TREATMENT MARKET, BY COUNTRY, 2023-2032 (USD MILLION) 52

TABLE 26 NORTH AMERICA: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TREATMENT TYPE, 2023-2032 (USD MILLION) 53

TABLE 27 NORTH AMERICA: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 53

TABLE 28 NORTH AMERICA: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE, 2023-2032 (USD MILLION) 54

TABLE 29 NORTH AMERICA: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 54

TABLE 30 NORTH AMERICA: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 54

TABLE 31 US: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TREATMENT TYPE, 2023-2032 (USD MILLION) 55

TABLE 32 US: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 55

TABLE 33 US: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE, 2023-2032 (USD MILLION) 56

TABLE 34 US: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 56

TABLE 35 US: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 56

TABLE 36 CANADA: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TREATMENT TYPE, 2023-2032 (USD MILLION) 57

TABLE 37 CANADA: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 57

TABLE 38 CANADA: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE, 2023-2032 (USD MILLION) 58

TABLE 39 CANADA: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 58

TABLE 40 CANADA: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 58

TABLE 41 LATIN AMERICA: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TREATMENT TYPE, 2023-2032 (USD MILLION) 59

TABLE 42 LATIN AMERICA: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 59

TABLE 43 LATIN AMERICA: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE, 2023-2032 (USD MILLION) 60

TABLE 44 LATIN AMERICA: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 60

TABLE 45 LATIN AMERICA: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 60

TABLE 46 EUROPE: KERATOCONUS TREATMENT MARKET, BY REGION, 2023-2032 (USD MILLION) 61

TABLE 47 EUROPE: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TYPE, 2023-2032 (USD MILLION) 62

TABLE 48 EUROPE: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 62

TABLE 49 EUROPE: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE,2023-2032 (USD MILLION) 63

TABLE 50 EUROPE: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE,2023-2032 (USD MILLION) 63

TABLE 51 EUROPE: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 63

TABLE 52 WESTERN EUROPE: KERATOCONUS TREATMENT MARKET, BY COUNTRY, 2023-2032 (USD MILLION) 64

TABLE 53 WESTERN EUROPE: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TREATMENT TYPE, 2023-2032 (USD MILLION) 65

TABLE 54 WESTERN EUROPE: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 65

TABLE 55 WESTERN EUROPE: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE, 2023-2032 (USD MILLION) 66

TABLE 56 WESTERN EUROPE: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 66

TABLE 57 WESTERN EUROPE: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 66

TABLE 58 GERMANY: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TREATMENT TYPE, 2023-2032 (USD MILLION) 67

TABLE 59 GERMANY: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 67

TABLE 60 GERMANY: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE, 2023-2032 (USD MILLION) 68

TABLE 61 GERMANY: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 68

TABLE 62 GERMANY: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 68

TABLE 63 FRANCE: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TREATMENT TYPE, 2023-2032 (USD MILLION) 69

TABLE 64 FRANCE: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 69

TABLE 65 FRANCE: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE, 2023-2032 (USD MILLION) 70

TABLE 66 FRANCE: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 70

TABLE 67 FRANCE: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 70

TABLE 68 UK: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TREATMENT TYPE, 2023-2032 (USD MILLION) 71

TABLE 69 UK: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 71

TABLE 70 UK: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE, 2023-2032 (USD MILLION) 72

TABLE 71 UK: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 72

TABLE 72 UK: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 72

TABLE 73 ITALY: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TREATMENT TYPE, 2023-2032 (USD MILLION) 73

TABLE 74 ITALY: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 73

TABLE 75 ITALY: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE, 2023-2032 (USD MILLION) 74

TABLE 76 ITALY: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 74

TABLE 77 ITALY: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 74

TABLE 78 SPAIN: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TREATMENT TYPE, 2023-2032 (USD MILLION) 75

TABLE 79 SPAIN: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 75

TABLE 80 SPAIN: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE, 2023-2032 (USD MILLION) 76

TABLE 81 SPAIN: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 76

TABLE 82 SPAIN: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 76

TABLE 83 REST OF WESTERN EUROPE: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TREATMENT TYPE, 2023-2032 (USD MILLION) 77

TABLE 84 REST OF WESTERN EUROPE: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 77

TABLE 85 REST OF WESTERN EUROPE: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE, 2023-2032 (USD MILLION) 78

TABLE 86 REST OF WESTERN EUROPE: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 78

TABLE 87 REST OF WESTERN EUROPE: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 78

TABLE 88 EASTERN EUROPE: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TREATMENT TYPE, 2023-2032 (USD MILLION) 79

TABLE 89 EASTERN EUROPE: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 79

TABLE 90 EASTERN EUROPE: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE, 2023-2032 (USD MILLION) 80

TABLE 91 EASTERN EUROPE: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 80

TABLE 92 EASTERN EUROPE: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 80

TABLE 93 ASIA-PACIFIC KERATOCONUS TREATMENT MARKET, BY COUNTRY, 2023-2032 (USD MILLION) 81

TABLE 94 ASIA-PACIFIC: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TYPE, 2023-2032 (USD MILLION) 82

TABLE 95 ASIA-PACIFIC: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 82

TABLE 96 ASIA-PACIFIC: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE,2023-2032 (USD MILLION) 83

TABLE 97 ASIA-PACIFIC: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE,2023-2032 (USD MILLION) 83

TABLE 98 ASIA-PACIFIC: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 83

TABLE 99 CHINA: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TREATMENT TYPE, 2023-2032 (USD MILLION) 84

TABLE 100 CHINA: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 84

TABLE 101 CHINA: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE, 2023-2032 (USD MILLION) 85

TABLE 102 CHINA: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 85

TABLE 103 CHINA: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 85

TABLE 104 INDIA: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TREATMENT TYPE, 2023-2032 (USD MILLION) 86

TABLE 105 INDIA: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 86

TABLE 106 INDIA: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE, 2023-2032 (USD MILLION) 87

TABLE 107 INDIA: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 87

TABLE 108 INDIA: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 87

TABLE 109 JAPAN: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TREATMENT TYPE, 2023-2032 (USD MILLION) 88

TABLE 110 JAPAN: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 88

TABLE 111 JAPAN: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE, 2023-2032 (USD MILLION) 89

TABLE 112 JAPAN: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 89

TABLE 113 JAPAN: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 89

TABLE 114 SOUTH KOREA: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TREATMENT TYPE, 2023-2032 (USD MILLION) 90

TABLE 115 SOUTH KOREA: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 90

TABLE 116 SOUTH KOREA: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE, 2023-2032 (USD MILLION) 91

TABLE 117 SOUTH KOREA: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 91

TABLE 118 SOUTH KOREA: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 91

TABLE 119 AUSTRALIA: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TREATMENT TYPE, 2023-2032 (USD MILLION) 92

TABLE 120 AUSTRALIA: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 92

TABLE 121 AUSTRALIA: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE, 2023-2032 (USD MILLION) 93

TABLE 122 AUSTRALIA: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 93

TABLE 123 AUSTRALIA: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 93

TABLE 124 REST OF ASIA-PACIFIC: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TREATMENT TYPE, 2023-2032 (USD MILLION) 94

TABLE 125 REST OF ASIA-PACIFIC: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 94

TABLE 126 REST OF ASIA-PACIFIC: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE, 2023-2032 (USD MILLION) 95

TABLE 127 REST OF ASIA-PACIFIC: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE, 2023-2032 (USD MILLION) 95

TABLE 128 REST OF ASIA-PACIFIC: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 95

TABLE 129 MIDDLE EAST & AFRICA: KERATOCONUS TREATMENT MARKET, BY REGION, 2023-2032 (USD MILLION) 96

TABLE 130 MIDDLE EAST & AFRICA: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TYPE, 2023-2032 (USD MILLION) 97

TABLE 131 MIDDLE EAST & AFRICA: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 97

TABLE 132 MIDDLE EAST & AFRICA: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE,2023-2032 (USD MILLION) 98

TABLE 133 MIDDLE EAST & AFRICA: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE,2023-2032 (USD MILLION) 98

TABLE 134 MIDDLE EAST & AFRICA: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 98

TABLE 135 MIDDLE EAST: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TYPE, 2023-2032 (USD MILLION) 99

TABLE 136 MIDDLE EAST: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 99

TABLE 137 MIDDLE EAST: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE,2023-2032 (USD MILLION) 100

TABLE 138 MIDDLE EAST: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE,2023-2032 (USD MILLION) 100

TABLE 139 MIDDLE EAST: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 100

TABLE 140 AFRICA: KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TYPE, 2023-2032 (USD MILLION) 101

TABLE 141 AFRICA: KERATOCONUS TREATMENT MARKET, BY TREATMENT TYPE, 2023-2032 (USD MILLION) 101

TABLE 142 AFRICA: KERATOCONUS TREATMENT MARKET, FOR LENSES, BY TYPE,2023-2032 (USD MILLION) 102

TABLE 143 AFRICA: KERATOCONUS TREATMENT MARKET, FOR SURGERY, BY TYPE,2023-2032 (USD MILLION) 102

TABLE 144 AFRICA: KERATOCONUS TREATMENT MARKET, BY END USER, 2023-2032 (USD MILLION) 102

TABLE 145 MAJOR MANUFACTURERS RANKING, 2020 105

TABLE 146 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL KERATOCONUS TREATMENT MARKET 106

TABLE 147 PRODUCT APPROVALS AND LAUNCHES 107

TABLE 148 ACQUISITIONS & SPIN OFF 108

TABLE 149 BAUSCH HEALTH COMPANIES INC.: PRODUCTS/SERVICES OFFERED 112

TABLE 150 BAUSCH HEALTH COMPANIES INC.: KEY DEVELOPMENTS 112

TABLE 151 NOVARTIS AG: PRODUCTS/SERVICES OFFERED 115

TABLE 152 BAUSCH HEALTH COMPANIES INC.: KEY DEVELOPMENTS 116

TABLE 153 THE COOPER COMPANIES, INC.: PRODUCTS/SERVICES OFFERED 118

TABLE 154 THE COOPER COMPANIES, INC.: KEY DEVELOPMENTS 118

TABLE 155 HOYA CORPORATION: PRODUCTS/SERVICES OFFERED 121

TABLE 156 HOYA CORPORATION: KEY DEVELOPMENTS 121

TABLE 157 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS/SERVICES OFFERED 125

TABLE 158 JOHNSON & JOHNSON SERVICES, INC: KEY DEVELOPMENTS 126

TABLE 159 CARL ZEISS MEDITEC AG: PRODUCTS/SERVICES OFFERED 128

TABLE 160 CARL ZEISS MEDITEC AG: KEY DEVELOPMENTS 128

TABLE 161 CONTAMAC: PRODUCTS/SERVICES OFFERED 130

TABLE 162 SEED CO., LTD: PRODUCTS/SERVICES OFFERED 133

TABLE 163 SEED CO., LTD: KEY DEVELOPMENTS 133

TABLE 164 SYNERGEYES: PRODUCTS/SERVICES OFFERED 135

TABLE 165 SYNERGEYES: KEY DEVELOPMENTS 136

TABLE 166 MENICON CO., LTD: PRODUCTS/SERVICES OFFERED 138

TABLE 167 MENICON CO., LTD: KEY DEVELOPMENTS 139

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 14

FIGURE 2 GLOBAL KERATOCONUS TREATMENT MARKET STRUCTURE 16

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 22

FIGURE 4 MARKET DYNAMICS OVERVIEW: KERATOCONUS TREATMENT MARKET 25

FIGURE 5 DRIVERS IMPACT ANALYSIS: KERATOCONUS TREATMENT MARKET 27

FIGURE 6 RESTRAINTS IMPACT ANALYSIS: KERATOCONUS TREATMENT MARKET 28

FIGURE 7 VALUE CHAIN: GLOBAL KERATOCONUS TREATMENT MARKET 30

FIGURE 8 PORTER’S FIVE FORCES ANALYSIS: GLOBAL KERATOCONUS TREATMENT MARKET 32

FIGURE 9 GLOBAL KERATOCONUS TREATMENT MARKET, BY KERATOCONUS TYPES, 2020 & 2027 (USD MILLION) 35

FIGURE 10 GLOBAL: KERATOCONUS TREATMENT MARKET, TREATMENT TYPE, 2020 & 2027 (USD MILLION) 39

FIGURE 11 GLOBAL KERATOCONUS TREATMENT MARKET, END USER, 2020 & 2027 (USD MILLION) 44

FIGURE 12 GLOBAL KERATOCONUS TREATMENT MARKET, BY REGION 2020 & 2027 (USD MILLION) 47

FIGURE 13 AMERICA: KERATOCONUS TREATMENT MARKET SHARE, BY REGION, 2020 (%) 49

FIGURE 14 NORTH AMERICA: KERATOCONUS TREATMENT MARKET SHARE, BY COUNTRY 2020 (%) 52

FIGURE 15 EUROPE: KERATOCONUS TREATMENT MARKET SHARE, BY REGION, 2020 (%) 61

FIGURE 16 WESTERN EUROPE: KERATOCONUS TREATMENT MARKET SHARE, BY COUNTRY 2020 (%) 64

FIGURE 17 ASIA-PACIFIC: KERATOCONUS TREATMENT MARKET SHARE, BY COUNTRY 2020 (%) 81

FIGURE 18 MIDDLE EAST & AFRICA: KERATOCONUS TREATMENT MARKET SHARE, BY REGION 2020 (%) 96

FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS 104

FIGURE 20 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN GLOBAL KERATOCONUS TREATMENT MARKET 106

FIGURE 21 SALES & OPERATING INCOME MARGIN, 2020 109

FIGURE 22 RESEARCH & DEVELOPMENT EXPENDITURE, 2020 109

FIGURE 23 BAUSCH HEALTH COMPANIES INC.: FINANCIAL OVERVIEW SNAPSHOT 111

FIGURE 24 BAUSCH HEALTH COMPANIES INC.: SWOT ANALYSIS 113

FIGURE 25 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT 115

FIGURE 26 NOVARTIS AG: SWOT ANALYSIS 116

FIGURE 27 THE COOPER COMPANIES, INC.: FINANCIAL OVERVIEW SNAPSHOT 117

FIGURE 28 THE COOPER COMPANIES, INC.: SWOT ANALYSIS 119

FIGURE 29 HOYA CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 120

FIGURE 30 HOYA CORPORATION: SWOT ANALYSIS 122

FIGURE 31 JOHNSON & JOHNSON SERVICES, INC.: FINANCIAL OVERVIEW SNAPSHOT 124

FIGURE 32 JOHNSON & JOHNSON SERVICES, INC.: SWOT ANALYSIS 126

FIGURE 33 CARL ZEISS MEDITEC AG: FINANCIAL OVERVIEW SNAPSHOT 127

FIGURE 34 CARL ZEISS MEDITEC AG: SWOT ANALYSIS 129

FIGURE 35 CONTAMAC: SWOT ANALYSIS 131

FIGURE 36 SEED CO., LTD: FINANCIAL OVERVIEW SNAPSHOT 132

FIGURE 37 SEED CO., LTD: SWOT ANALYSIS 134

FIGURE 38 SYNERGEYES: SWOT ANALYSIS 136

FIGURE 39 MENICON CO., LTD: FINANCIAL OVERVIEW SNAPSHOT 137

FIGURE 40 MENICON CO., LTD: SWOT ANALYSIS 139